
MSN Group to unveil drug to treat epilepsy
The Hindu
Drugmaker MSN Group is focussed on introducing generic products for various therapies at a fraction of the innovator’s product price once the patent expires.
“In the next 5-6 years, MSN will bring products, once the patent expires, at one-tenth of the cost,” executive director Bharat Reddy said, announcing that MSN will unveil anti-epilepsy drug Brivanext in India in the next few days.
More Related News

The Karnataka government has drafted a comprehensive master plan for the integrated development of Kukke Subrahmanya temple, the State’s highest revenue-generating temple managed by the Hindu Religious Institutions and Charitable Endowments Department. The redevelopment initiative is estimated to cost around ₹254 crore and aims to enhance infrastructure and facilities for devotees.